Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H17FN2O3 |
| Molecular Weight | 280.2948 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2
InChI
InChIKey=KELNNWMENBUHNS-NSHDSACASA-N
InChI=1S/C14H17FN2O3/c1-4-11-13(18)16-10-6-5-9(15)7-12(10)17(11)14(19)20-8(2)3/h5-8,11H,4H2,1-3H3,(H,16,18)/t11-/m0/s1
| Molecular Formula | C14H17FN2O3 |
| Molecular Weight | 280.2948 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Opaviraline (also known as GW 420867), a nonnucleoside reverse transcriptase inhibitor that was studied for the treatment of HIV infections. The drug participated in clinical trials phase II in Germany, in South Africa, and in the United Kingdom, however, these studies were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors. | 2000 Apr 10 |
|
| Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors. | 2000 May |
|
| The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs. | 2005 Apr 25 |
|
| Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile. | 2006 Aug |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:56 GMT 2025
by
admin
on
Mon Mar 31 18:29:56 GMT 2025
|
| Record UNII |
Q3A8EU2NMU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C97453
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB07884
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
Q3A8EU2NMU
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
C90786
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
154048
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
300000034254
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL301370
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
178040-94-3
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
DTXSID60170415
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY | |||
|
8020
Created by
admin on Mon Mar 31 18:29:56 GMT 2025 , Edited by admin on Mon Mar 31 18:29:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
